Blog from April, 2020

(Köster Lab)

PhD Position in Computational Neuroscience (f/m/d)

funded position for 3 years


Background: The human brain consists of 86 × 10􀀂 neurons, whereas the zebrafish larval

brain only contains approximately 10􀀁. Despite its smaller size, the basic neuronal architecture

or bauplan of the zebrafish brain is largely comparable to its human counterpart. Moreover,

not only are the basic building blocks and neural circuitry evolutionary conserved, but in

addition larval zebrafish are small and transparent, thereby offering a unique opportunity to

observe neuronal activity with high resolution microscopy. Indeed, the zebrafish was the first

vertebrate organism in which neuronal activity throughout the whole brain has been recorded

in real time (Ahrens et al., 2013). Although we can now literally see a fish thinking, the obtained

data sets are large and require computational methods to gain fundamental insights into the

activity patterns of neural networks and their mutual interplay (Haesemeyer et al., 2019).


Project: We are looking for an enthusiastic PhD student to analyze, model, and possibly

predict neural activity. In the PhD project, the candidate will analyze activity patterns of nerve

cells throughout the entire brain obtained by advanced imaging techniques such as light sheet

microscopy. This requires, first, the identification and segmentation of signals and their 3Dreconstruction

over time, and, second, the registration of individual brains and their

corresponding activity patterns onto a reference brain in order to compare different data sets.


To this end, you will develop deep learning approaches within a Python framework. Since the

imaging datasets are usually large (in the terabyte range), GPU-based methods to accelerate

data processing routines will be implemented together with existing frameworks such as

advanced normalization tools (ANTs). In addition, the candidate should be interested in

working in an interdisciplinary and cutting-edge research area together with engineers,

biologists, and data scientists.


The goal of the PhD project is to analyze and quantify neuronal activity patterns across the

entire brain in response to externally provided stimuli mapped onto a reference brain. This will

provide fundamental insights into brain function in health and disease and may ultimately also

lead to novel and better treatments of neuropsychiatric disorders such as depression, anxiety,

and drug addiction.


You should have a very good knowledge in coding (in particular Python) and computation in

general. Ideally, you already have experience in the implementation of deep learning

techniques and the simulation and modeling of neuronal networks. Prior knowledge in biology

or microscopy is not necessary, but a keen interest in neuroscience is encouraged. You will

work in an international team together with neurobiologists and microfluidic engineers; thus

solid conversation skills in English is required.


The PhD position is offered in the Köster Lab at the Zoological Institute (https://www.tubraunschweig.

de/en/zoology) in Braunschweig, Germany. The preferred starting date is the

01.07.2020, and the duration is 3 years. The position is part-time suitable, but should be

occupied 100% and is aimed to lead to a PhD degree as Dr. rer. nat. at the Life Sciences

Faculty of the Technical University (TU) of Braunschweig.


The payment is made according to task assignment and fulfillment of personal requirements

to salary group EG 13 TV-L, 65% (approximately: 2.000 €/month net). Applicants from non-EU

countries may have to successfully complete a visa process before hiring can take place and

are welcomed to apply.


The TU Braunschweig aims to increase the share of women in academic positions.

Applications from female candidates are very welcome. Where candidates have equal

qualifications, preference will be given to female applicants. Candidates with handicaps will be

preferred if equally qualified. Please enclose a proof when applying for the position.

Applications: should be sent by e-mail to Reinhard Köster (r.koester@tu-bs.de), and must

contain the following documents.


􀀁 Motivation Letter including contact information for two references

􀀁 Curriculum Vitae including complete address, phone number, email address,

educational background, language skills, and work experience

􀀁 copies of bachelor and master degrees and transcript of grades in original language

and in English or German translation

􀀁 additional documents should be provided on request


All documents should be in the PDF format; preferably, please provide the entire application

in a single file. Personal data and documents relating to the application process will be stored

electronically. Please note that application costs cannot be refunded. Deadline for

applications: until position is filled.


For any questions, please contact: Dr. Jakob von Trotha or Prof. Reinhard Köster

Email: j.von-trotha@tu-braunschweig.de, r.koester@tu-bs.de


Further reading:

Ahrens, M.B., Orger, M.B., Robson, D.N., Li, J.M., & Keller, P.J. (2013) Whole-brain functional imaging at cellular

resolution using light-sheet microscopy. Nat Meth, 10, 413–420.


Haesemeyer, M., Schier, A.F., & Engert, F. (2019) Convergent Temperature Representations in Artificial and

Biological Neural Networks. Neuron, 103, 1123–1134.e1126.

Published: 2020-04-02

Uppsala University is a comprehensive research-intensive university with a strong international standing. Our mission is to pursue top-quality research and education and to interact constructively with society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. Uppsala University has 46.000 students, 7.300 employees and a turnover of SEK 7.3 billion.

The Department of Immunology, Genetics and Pathology at Uppsala University (www.igp.uu.se) has a broad research profile with strong research groups focused on cancer, autoimmune and genetic diseases. A fundamental idea at the department is to stimulate translational research and thereby closer interactions between medical research and health care. Research is presently conducted in the following areas: medical and clinical genetics, clinical immunology, pathology, neuro-oncology, vascular biology, radiation science and molecular tools. Department activities are also integrated with the units for Oncology, Clinical Genetics, Clinical Immunology, Clinical Pathology, and Hospital Physics at Akademiska sjukhuset, Uppsala. The department has teaching assignments in several education programmes, including Master Programmes, at the Faculty of Medicine, and in a number of educations at the Disciplinary Domain of Science and Technology. The department has a yearly turnover of around SEK 420 million, out of which more than half is made up of external funding. The staff amounts to approximately 345 employees, out of which 100 are PhD-students, and there are in total more than 700 affiliated people.

Project description: Diabetes is the leading cause of kidney disease, and about 1 in 4 adults with diabetes has kidney disease. So far, genome-wide association studies identified at least 16 DNA regions that are robustly associated with the risk of diabetic kidney disease. However, only a few of these DNA regions contain genes known to play a role in kidney disease. Identifying and characterizing mechanisms by which causal genes act is essential, since such genes may encode targets that can be translated into efficient medication in the future, and there are currently no drugs that can prevent or cure diabetic kidney disease. What’s more, model systems to systematically characterise candidate genes in vivo are not currently available.
In this project, we aim to develop and validate an image and CRISPR-Cas9-based zebrafish model system that is suitable for systematic characterization of genes and drugs with an anticipated role in kidney disease, and to use this model system to characterise candidate genes.

Work description: To make this project a success, the candidate will: 1) identify traits of relevance for kidney disease that can be visualised in zebrafish embryos or larvae using an automated microscopy set-up; 2) help develop scripts to automatically quantify such traits objectively and in high throughput, in collaboration with local image-analysis experts; 3) develop additional readouts that can be characterised at the single larval level after imaging; 4) characterise the effect of proof-of-concept exposures (i.e. metabolic challenges, exposure to chemicals or drugs, CRISPR-induced mutations in proof of concept genes) on anticipated disease-related traits; 5) use validated readouts to characterise previously unanticipated candidate genes.
This workflow additionally requires the successful candidate to 6) micro-inject to generate CRISPR founders; 7) prepare samples for downstream biochemical and sequencing analyses using a pipetting robot; 8) manage and statistically analyse large amounts of data efficiently; 9) place new results in the context of the existing knowledge base; and 10) disseminate new insights into manuscripts for publication in peer-reviewed journals and presentations at (inter)national conferences.

Qualifications: Applications are accepted from highly motivated candidates with a PhD in Molecular Biology, Molecular Epidemiology, or similar. The PhD must have been completed within three years of the application deadline. If you received your PhD earlier but special circumstances apply (i.e. prolonged periods of illness, parental leave, military service, union duties and others of similar character) then you may also be eligible to apply. Applicants must have a documented and broad competence in basic molecular biology methodology, including working experience with the zebrafish as a model system, DNA mutagenesis, and fluorescence or confocal microscopy. A successful candidate should be a highly motivated, organised, reliable team player that can also work independently and is proficient in communicating in English, both orally and in writing. Prior knowledge of and experience in working with the kidneys,  data management, microinjections, epidemiology, biostatistics and/or image- based analyses are considered additional strenghts.

The application should include a cover letter describing yourself, your research interests and your experience relevant to this position (as described above); a CV; a list of publications in peer-reviewed journals; and contact details for at least two reference persons. If available, letters of recommendation can also be included.

Salary: Individual salary.

Starting date: 01-06-2020 or as otherwise agreed.

Type of employment: Temporary position of 2 years according to central collective agreement.

Scope of employment: 100 %

For further information about the position please contact: Marcel den Hoed, marcel.den_hoed@igp.uu.se, 070-4250752.

Please submit your application by 23 April 2020, UFV-PA 2020/1041.

Are you considering moving to Sweden to work at Uppsala University? If so, you will find a lot of information about working and living in Sweden at www.uu.se/joinus. You are also welcome to contact International Faculty and Staff Services at ifss@uadm.uu.se.

Please do not send offers of recruitment or advertising services.

Submit your application through Uppsala University´s recruitment system, which can be accessed using the following link:

https://www.uu.se/en/about-uu/join-us/details/?positionId=323985


Placement: Department of Immunology, Genetics and Pathology

Type of employment: Full time , Temporary position longer than 6 months

Pay: Fixed salary

Number of positions: 1

Working hours: 100%

Town: Uppsala

County: Uppsala län

Country: Sweden

Union representative: Seko Universitetsklubben seko@uadm.uu.se
ST/TCO tco@fackorg.uu.se
Saco-rådet saco@uadm.uu.se

Number of reference: UFV-PA 2020/1041

Last application date: 2020-04-23

Published: 2020-04-02

Uppsala University is a comprehensive research-intensive university with a strong international standing. Our mission is to pursue top-quality research and education and to interact constructively with society. Our most important assets are all the individuals whose curiosity and dedication make Uppsala University one of Sweden’s most exciting workplaces. Uppsala University has 46.000 students, 7.300 employees and a turnover of SEK 7.3 billion.

The Department of Immunology, Genetics and Pathology at Uppsala University (www.igp.uu.se) has a broad research profile with strong research groups focused on cancer, autoimmune and genetic diseases. A fundamental idea at the department is to stimulate translational research and thereby closer interactions between medical research and health care. Research is presently conducted in the following areas: medical and clinical genetics, clinical immunology, pathology, neuro-oncology, vascular biology, radiation science and molecular tools. Department activities are also integrated with the units for Oncology, Clinical Genetics, Clinical Immunology, Clinical Pathology, and Hospital Physics at Akademiska sjukhuset, Uppsala. The department has teaching assignments in several education programmes, including Master Programmes, at the Faculty of Medicine, and in a number of educations at the Disciplinary Domain of Science and Technology. The department has a yearly turnover of around SEK 420 million, out of which more than half is made up of external funding. The staff amounts to approximately 345 employees, out of which 100 are PhD-students, and there are in total more than 700 affiliated people.

Project description: Diabetes is the leading cause of kidney disease, and about 1 in 4 adults with diabetes has kidney disease. So far, genome-wide association studies identified at least 16 DNA regions that are robustly associated with the risk of diabetic kidney disease. However, only a few of these DNA regions contain genes known to play a role in kidney disease. Identifying and characterizing mechanisms by which causal genes act is essential, since such genes may encode targets that can be translated into efficient medication in the future, and there are currently no drugs that can prevent or cure diabetic kidney disease. What’s more, model systems to systematically characterise candidate genes in vivo are not currently available.
In this project, we aim to develop and validate an image and CRISPR-Cas9-based zebrafish model system that is suitable for systematic characterization of genes and drugs with an anticipated role in kidney disease, and to use this model system to characterise candidate genes.

Work description: To make this project a success, the candidate will: 1) identify traits of relevance for kidney disease that can be visualised in zebrafish embryos or larvae using an automated microscopy set-up; 2) help develop scripts to automatically quantify such traits objectively and in high throughput, in collaboration with local image-analysis experts; 3) develop additional readouts that can be characterised at the single larval level after imaging; 4) characterise the effect of proof-of-concept exposures (i.e. metabolic challenges, exposure to chemicals or drugs, CRISPR-induced mutations in proof of concept genes) on anticipated disease-related traits; 5) use validated readouts to characterise previously unanticipated candidate genes.
This workflow additionally requires the successful candidate to 6) micro-inject to generate CRISPR founders; 7) prepare samples for downstream biochemical and sequencing analyses using a pipetting robot; 8) manage and statistically analyse large amounts of data efficiently; 9) place new results in the context of the existing knowledge base; and 10) disseminate new insights into manuscripts for publication in peer-reviewed journals and presentations at (inter)national conferences.

Qualifications: Applications are accepted from highly motivated candidates with a PhD in Molecular Biology, Molecular Epidemiology, or similar.
Applicants must have a documented and broad competence in basic molecular biology methodology, including working experience with the zebrafish as a model system, DNA mutagenesis, and fluorescence or confocal microscopy. A successful candidate should be a highly motivated, organised, reliable team player that can also work independently and is proficient in communicating in English, both orally and in writing. Prior knowledge of and experience in working with the kidneys,  data management, microinjections, epidemiology, biostatistics and/or image- based analyses are considered additional strenghts.

The application should include a cover letter describing yourself, your research interests and your experience relevant to this position (as described above); a CV; a list of publications in peer-reviewed journals; and contact details for at least two reference persons. If available, letters of recommendation can also be included.

Salary: Individual salary.

Starting date: 01-06-2020 or as otherwise agreed.

Type of employment: Temporary position ending 31-05-2022.

Scope of employment: 100 %

For further information about the position please contact: Marcel den Hoed, marcel.den_hoed@igp.uu.se, 070-4250752.

Please submit your application by 23 April 2020, UFV-PA 2020/1042.

Are you considering moving to Sweden to work at Uppsala University? If so, you will find a lot of information about working and living in Sweden at www.uu.se/joinus. You are also welcome to contact International Faculty and Staff Services at [ifss@uadm.uu.se|mailto:ifss@uadm.uu.se].

Please do not send offers of recruitment or advertising services.

Submit your application through Uppsala University´s recruitment system, which can be accessed using the link below:

https://www.uu.se/en/about-uu/join-us/details/?positionId=323980


Placement: Department of Immunology, Genetics and Pathology

Type of employment: Full time , Temporary position longer than 6 months

Pay: Individual salary

Number of positions: 1

Working hours: 100%

Town: Uppsala

County: Uppsala län

Country: Sweden

Union representative: Seko Universitetsklubben seko@uadm.uu.se
ST/TCO tco@fackorg.uu.se
Saco-rådet saco@uadm.uu.se

Number of reference: UFV-PA 2020/1042

Last application date: 2020-04-23  Page Title

När du har kontakt med oss på Uppsala universitet med e-post så innebär det att vi behandlar dina personuppgifter. För att läsa mer om hur vi gör det kan du läsa här: http://www.uu.se/om-uu/dataskydd-personuppgifter/

E-mailing Uppsala University means that we will process your personal data. For more information on how this is performed, please read here: http://www.uu.se/en/about-uu/data-protection-policy

A postdoctoral position is available in the group of Professor Felix B. Engel. The team studies heart development and applies this knowledge to enhance endogenous cardiac repair processes or to engineer cardiac tissues for transplantation. Main topics are currently adhesion GPCRs, cardiomyocyte proliferation, centrosome biology/non-centrosomal microtubule-organizing center, electroconductive hydrogels, and spider silk based materials. To achieve this, the group utilizes for example zebrafish and mouse as model organisms, hiPSCs, as well as state-of-the-art molecular and cell biology techniques. The Engel group is located in the Translational Research Center of the University Hospital Erlangen. Our laboratory publishes regularly in high profile journals such as Cell Research, Advanced Functional Materials, PNAS, eLife, Development, and Biomaterials.


Background of the project: Cardiomyocytes establish after birth a cell cycle arrest associated with cytokinesis failure and centrosome disintegration, which appears strict as cardiac tumors are very rare. In addition, it is extremely difficult to induce tumor-relevant processes like proliferation and migration in adult cardiomyocytes. Thus, we hypothesize that cardiomyocyte differentiation represent an excellent model to identify new potential targets to treat cancer.


Funding: The project is funded by the Wilhelm Sander-Foundation. Salary: E13, 100% for 2 years with possible extension.


Job description: We are seeking a highly motivated and ambitious postdoctoral candidate with a strong background in cell, developmental and/or molecular biology with experience in life cell imaging, the model system zebrafish and/or cancer biology to join our team. The candidate will investigate the effect of candidate genes obtained from studying heart development on colorectal cancer growth and metastasis in an embryonic zebrafish xenograft model and in vitro systems.Starting date for this position is the 1 July 2020, or upon agreement with the chosen candidate.


Application: Please contact Prof. Engel for further information and send your application preferable by email to:


Prof. Dr. rer. nat. Dipl. Ing. Felix B. Engel

Universitätsklinikum Erlangen

Experimentelle Nieren- und Kreislaufforschung

Nephropathologische Abteilung, Pathologisches Institut

Schwabachanlage 12 (TRC)

91054 Erlangen


phone:            +49 (0) 9131-8525699  

e-mail:             felix.engel@uk-erlangen.de


Deadline for applications: 9 May 2020, 23.59 pm.